✦ LIBER ✦

Randomized, Double-Blind, Double-Dummy, Multicenter Trial of a Herbal Preparation of Myrrh, Camomile and Coffee Coal Compared to Mesalamine in Maintaining Remission in Ulcerative Colitis

✍ Scribed by Langhorst, Jost ;Varnhagen, Ines ;Schneider, Berthold ;Goos, Karl-Heinz ;Albrecht, Uwe W. ;Rueffer, Andreas ;Stange, Rainer ;Michalsen, Andreas ;Dobos, Gustav J.

Book ID: 123018663
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 95 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(11)61057-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P281 Randomized, double-blind, double-du

P281 Randomized, double-blind, double-dummy trial of myrrh, camomile and coffee charcoal compared to mesalazine in maintaining remission in ulcerative colitis

✍ J. Langhorst; A. Westendorf; M. Knott; S. Schneider; K. Goos; U. Albrecht; A. Ru 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 51 KB

OA07.03. Randomized, double-blind, doubl

OA07.03. Randomized, double-blind, double-dummy trial of myrrh, chamomile, coffee charcoal compared to mesalazine in maintaining remission in ulcerative colitis

✍ Langhorst, J; Westendorf, A; Knopp, M; Schneider, S; Goos, K; Albrecht, U; Rueff 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 104 KB

1158 Double-Blind, Double-Dummy, Randomi

1158 Double-Blind, Double-Dummy, Randomized, Placebo-Controlled, Multicenter Trial of Budesonide and Mesalamine in Collagenous Colitis

✍ Stephan Miehlke; Ahmed Madisch; Limas Kupcinskas; Gerhard Heptner; Günter Böhm; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Tu1122 Optimal Dosing of Mesalamine for

Tu1122 Optimal Dosing of Mesalamine for Maintenance of Clinical Remission in Patients With Distal Ulcerative Colitis and Residual Endoscopic Activity: A Subgroup Analysis of a Double-Blind, Double-Dummy, Randomized, Controlled, Dose-Ranging Study

✍ Kruis, Wolfgang; Greinwald, Roland; Mueller, Ralph 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 246 KB

Budesonide Mxx® 9 mg for the Induction o

Budesonide Mxx® 9 mg for the Induction of Remission of Mild-to-Moderate Ulcerative Colitis (UC): Data From a Multicenter, Randomized, Double-Blind Placebo-Controlled Study in North America and India

✍ William J. Sandborn; Simon Travis; Luigi Moro; E. David Ballard; Philip Yeung; W 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 494 KB

Budesonide-MMx® 9 mg for Induction of Re

Budesonide-MMx® 9 mg for Induction of Remission of Mild-to-Moderate Ulcerative Colitis (UC): Data From a Multicenter, Randomized, Double-Blind Placebo-Controlled Study in the Europe, Russia, Israel and Australia

✍ William J. Sandborn; Simon Travis; Silvio Danese; Limas Kupcinskas; Olga Alexeev 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 186 KB